X

LLY

Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%

Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab…

Eli Lilly (LLY) is paving the way to a strong 2021

Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30%…

Eli Lilly and Company (LLY) Q3 2020 Earnings Call Transcript

Eli Lilly and Company  (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020  Corporate Participants: Kevin Hern — Vice President,…

Eli Lilly & Co. (LLY) Q2 2020 Earnings Call Transcript

Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 Presentation: Operator Ladies and gentlemen, thank…

Eli Lilly (LLY) appears to be on a strong footing with COVID-19 drug development efforts

Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the…

Eli Lilly & Co (NYSE: LLY) Q1 2020 Earnings Call Transcript

Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern — Vice President, Investor Relations…

Eli Lilly (LLY) reports Q1 2020 earnings results

Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic,…

Eli Lilly & Co  (NYSE: LLY) Q4 2019 Earnings Call Transcript

Eli Lilly & Co  (NYSE: LLY) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Kevin Hern — Vice President of Investor…

Eli Lilly (NYSE: LLY): Q4 2019 Earnings Snapshot

— Eli Lilly and Company (NYSE: LLY) reported its fourth-quarter 2019 adjusted earnings of $1.73 per share versus $1.52 per…